Detect prostate cancer (when no symptoms are present)
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms.[1][2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.[2]
Screening precedes a diagnosis and subsequent treatment. The digital rectal examination (DRE) is one screening tool, during which the prostate is manually assessed through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen (PSA) in the blood. The evidence remains insufficient to determine whether screening with PSA or DRE reduces mortality from prostate cancer.[1] A 2013 Cochrane review concluded PSA screening results in "no statistically significant difference in prostate cancer-specific mortality...".[3] The American studies were determined to have a high bias. European studies included in this review were of low bias and one reported "a significant reduction in prostate cancer-specific mortality." PSA screening with DRE was not assessed in this review. DRE was not assessed separately.[3]
Most recent guidelines have recommended that the decision whether or not to screen should be based on shared decision-making,[4] so that men are informed of the risks and benefits of screening.[5][6] In 2012, the American Society of Clinical Oncology recommends screening be discouraged for those who are expected to live less than ten years, while for those with a longer life expectancy a decision should be made by the person in question. In general, they conclude that based on recent research, "it is uncertain whether the benefits associated with PSA testing for prostate cancer screening are worth the harms associated with screening and subsequent unnecessary treatment."[7]
Prostate biopsies are used to diagnose prostate cancer but are not done on asymptomatic men and therefore are not used for screening.[8][9] Infection after prostate biopsy occurs in about 1%, while death occurs as a result of biopsy in 0.2%.[10][11] Prostate biopsy guided by magnetic resonance imaging has improved the diagnostic accuracy of the procedure.[12][13]
^ abPDQ Screening and Prevention Editorial Board (2018). "Prostate Cancer Screening (PDQ®): Health Professional Version". PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US). PMID 26389383. This article incorporates text from this source, which is in the public domain.
^ ab"Prostate Cancer Screening-Professional Version". National Cancer Institute. 1980-01-01. Retrieved 2018-02-28. This article incorporates text from this source, which is in the public domain.
^ abCite error: The named reference :7 was invoked but never defined (see the help page).
^"Prostate Cancer Guidelines". Emedicine. 2017. Retrieved 18 February 2018.
^Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, et al. (January 2013). "Prostate specific antigen best practice statement: 2009 update". The Journal of Urology. 189 (1 Suppl): S2–S11. doi:10.1016/j.juro.2012.11.014. PMID 23234625.
^Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. (Mar–Apr 2010). "American Cancer Society guideline for the early detection of prostate cancer: update 2010". CA: A Cancer Journal for Clinicians. 60 (2): 70–98. doi:10.3322/caac.20066. PMID 20200110. S2CID 21548482.
^Basch E, Oliver TK, Vickers A, Thompson I, Kantoff P, Parnes H, et al. (August 2012). "Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion". Journal of Clinical Oncology. 30 (24): 3020–5. doi:10.1200/JCO.2012.43.3441. PMC 3776923. PMID 22802323.
^Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. (March 2017). "Complications After Systematic, Random, and Image-guided Prostate Biopsy". European Urology. 71 (3): 353–365. doi:10.1016/j.eururo.2016.08.004. hdl:11585/559951. PMID 27543165.
^Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. (December 2013). "Systematic review of complications of prostate biopsy". European Urology. 64 (6): 876–92. doi:10.1016/j.eururo.2013.05.049. PMID 23787356.
^Bennett HY, Roberts MJ, Doi SA, Gardiner RA (June 2016). "The global burden of major infectious complications following prostate biopsy". Epidemiology and Infection. 144 (8): 1784–91. doi:10.1017/S0950268815002885. PMC 9150640. PMID 26645476. S2CID 82280.
^Cite error: The named reference CMAJ2014 was invoked but never defined (see the help page).
^Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG (September 2015). "Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis". European Urology. 68 (3): 438–50. doi:10.1016/j.eururo.2014.11.037. PMID 25480312.
^Wegelin O, van Melick HH, Hooft L, Bosch JL, Reitsma HB, Barentsz JO, et al. (April 2017). "Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?". European Urology. 71 (4): 517–531. doi:10.1016/j.eururo.2016.07.041. PMID 27568655.
and 25 Related for: Prostate cancer screening information
Prostatecancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder. Abnormal growth of prostate...
be a reliable screening test for prostatecancer. This examination may be used: for the diagnosis of prostatic disorders, benign prostatic hyperplasia and...
The objective of cancerscreening is to detect cancer before symptoms appear, involving various methods such as blood tests, urine tests, DNA tests, and...
2018, the Task Force recommended that prostate-specific antigen (PSA)-based screening for prostatecancerscreenings be an individual decision for men between...
diagnosed with screening (in the prostatecancerscreening era) and pre prostatecancerscreening eras (without screening) were from 2-6%, and from 15 to...
or by manipulation of the prostate during surgery or catheterization. Additionally many prostatecancers detected by screening develop so slowly that they...
significant risk of overdiagnosis with widespread screening in the general population, prostatecancerscreening is controversial. If a tumour is confirmed,...
with cancer of prostate. These diagnoses and deaths from this form of cancer have been confirmed by public information and reports. Prostatecancer is a...
importance of prostate health and prostatecancer awareness Providing easily accessible prostate health screenings and prostatecancerscreenings Educating...
for prostatecancerscreening is controversial and not necessarily indicated in every evaluation for BPH. Benign prostatic hyperplasia and prostate cancer...
Smith Mobile ProstateCancerScreening Unit Program was launched to support prostate health in Black communities through mobile screening appointments...
treatment. For some common cancers the staging process is well-defined. For example, in the cases of breast cancer and prostatecancer, doctors routinely can...
Breast cancerscreening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis...
problem especially applies to prostatecancer and PSA screening. Some cancer researchers have argued that negative cancer clinical trials lack sufficient...
against screening for skin cancer, oral cancer, lung cancer, or prostatecancer in men under 75. Routine screening is not recommended for bladder cancer, testicular...
gene have increased rates of developing prostatecancer, screening for prostatecancer in men with beast cancer who are 45 years or older and carry a BRCA2...
1976 Doctor Who serial The Brain of Morbius 4KScore test for prostatecancerscreening Kenn Borek Air, a Canadian airline IATA code Search for "4k" or...
square meals a day and free medical care if they were found to have prostatecancer. Hudson's early experience with seeing patients dying at a tuberculosis...
DA; Roth, B; Williams, J; Nam, RK (Jul 16, 2012). "Screening for ProstateCancer With Prostate-Specific Antigen Testing: American Society of Clinical...
"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostatecancer incidence trends". Journal of the National Cancer Institute. 94 (13):...
of prostatecancer (from 69% in the 1970s to 100% in 2006) to screening and diagnosis and due to the fact that men that participate in screening tend...
examine the human breast for diagnosis and screening. The goal of mammography is the early detection of breast cancer, typically through detection of characteristic...